Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,495 | -12,266 | -38,966 | -24,320 | -16,108 |
| Depreciation Amortization | 883 | 252 | 21 | 16 | 13 |
| Accounts payable and accrued liabilities | 266 | 1,700 | -352 | 91 | -488 |
| Other Working Capital | -4,419 | 2,431 | -724 | -3,131 | -5,439 |
| Other Operating Activity | 913 | -849 | 6,694 | 473 | 467 |
| Operating Cash Flow | $-30,852 | $-8,732 | $-33,327 | $-26,871 | $-21,555 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -145 | -10 | N/A | N/A | N/A |
| Investing Cash Flow | $-145 | $-10 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 14,146 | 14,146 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | -2,057 | -1,216 | -811 |
| Common Stock Issued | 69,002 | N/A | 50,070 | 3 | N/A |
| Other Financing Activity | -4,762 | -230 | -4,532 | 0 | 0 |
| Financing Cash Flow | $78,386 | $13,916 | $43,481 | $-1,213 | $-811 |
| Beginning Cash Position | 48,942 | 48,942 | 38,788 | 38,788 | 38,788 |
| End Cash Position | 96,331 | 54,116 | 48,942 | 10,704 | 16,422 |
| Net Cash Flow | $47,389 | $5,174 | $10,154 | $-28,084 | $-22,366 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,852 | -8,732 | -33,327 | -26,871 | -21,555 |
| Capital Expenditure | -145 | -10 | N/A | N/A | N/A |
| Free Cash Flow | -30,997 | -8,742 | -33,327 | -26,871 | -21,555 |